CJC-1295

Growth hormone secretagogue analog

CJC-1295 is researched around growth-hormone signaling, recovery, sleep, and body composition. PeptideStack keeps it evidence-limited and uses it to track recovery variables rather than imply performance outcomes.

CJC-1295 DACModified GRF 1-29

What It Is

Mechanism: CJC-1295 is a growth hormone-releasing hormone analog designed to increase pulsatile growth-hormone exposure in research contexts.

Research Areas

GH-axis research

Human pharmacology evidence

Hours to weeks in studies

Sleep and recovery tracking

Practical tracking need

Weeks

Ipamorelin comparison context

Community interest; clinical frequency not established

Ongoing

Evidence Context

Top labels, trials, papers, and regulatory sources tied to CJC-1295. This is research context, not treatment advice.

1 sources

PubMedHuman2006

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

Human pharmacology research helps explain CJC-1295 interest while leaving performance and body-composition claims unproven.

GH-axis mechanism contextHuman pharmacology studyJournal of Clinical Endocrinology and Metabolism16352683

What to track first

The right tracking lens is sleep quality, recovery, hunger, edema, glucose context, training load, and stack overlap.

• Track sleep, recovery, appetite, edema, glucose notes, and training load.

• Separate CJC-1295 from ipamorelin or other secretagogues if both are present.

• Keep clinician context and lab markers visible when GH-axis concerns exist.

Water retention or swelling

Reported with GH-axis agentsVariable

Track weight, edema, and blood-pressure context.

Hunger or sleep changes

Reported by usersVariable

Track timing, meals, and sleep quality.

Glucose-context concern

Clinically relevantHigh context need

GH-axis changes can matter in metabolic disease.

Research Status

Investigational; consumer performance use is not an approved drug indication.

Stack Context

Sleep/recovery context

Track sleep score, soreness, HRV, hunger, and training load.

GH-axis caution context

Track labs and clinician direction when endocrine concerns exist.

Warnings

• Endocrine, cancer, diabetes, and pregnancy contexts require clinician guidance.

• Do not infer body-composition outcomes from GH pharmacology alone.

• Unregulated peptide sourcing carries quality and sterility risk.

Start Tracking

Track CJC-1295 with sleep, recovery, appetite, edema, training load, and lab context.

CJC-1295 belongs in the performance section as a careful GH-axis tracking profile, not a promise page.

Open App Funnel View Tools